米R-1236:瘤发育和进展的关键控制者:专注于生物功能和分子机制
Zeinab Babaei1, Mohammad Keyvanloo Shahrestanaki2, Mahmoud Aghaei3
1Department of Clinical Biochemistry and Biophysics, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran.
Pathology, research and practice
|July 7, 2023
概括
微RNA 1236 (miR-1236) 在癌症的发展和进展中起着至关重要的作用. 本次审查强调了miR-1236作为各种癌症的潜在诊断标记物和治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 癌症仍然是全球疾病和死亡的主要原因.
- 微RNAs (miRNAs) 是基因表达的关键调节者,涉及到癌症的发病.
- 微RNA 1236 (miR-1236) 已成为瘤发展的重要因素.
研究的目的:
- 审查和综合目前关于miR-1236在癌症中的作用的知识.
- 讨论miR-1236参与瘤进展的基本细胞和分子机制.
- 探索miR-1236作为诊断标记物和治疗点的潜力.
主要方法:
- 在癌症中调查miR-1236的研究的文献综述.
- 对miR-1236的目标基因和信号通路的分析.
- 通过长非编码RNAs (lncRNAs) 和圆形RNAs (circRNAs) 检查miR-1236的调节.
主要成果:
- miR-1236影响癌细胞的生长,迁移,入侵,亡和耐药性.
- miR-1236参与上皮层-介质细胞过渡 (EMT),这是转移的一个关键过程.
- miR-1236的失调与瘤诊断和预后有关.
结论:
- miR-1236是癌症进展的多个方面的一个关键调节剂.
- 新出现的证据支持miR-1236作为一种非侵入性诊断生物标志物的潜力.
- 向miR-1236为癌症治疗提供了一个有前途的治疗策略.
相关概念视频
02:38Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
02:07Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
01:22MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K